Jeffrey Schomburger - Procter Gamble Global Sales Officer
PGCO34 Stock | BRL 57.91 0.64 1.12% |
Executive
Mr. Jeffrey K. Schomburger is Global Sales Officer of the Company. since 2015.
Age | 55 |
Tenure | 9 years |
Phone | 513 983 1100 |
Web | https://www.pginvestor.com |
Procter Gamble Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 10 records | EXECUTIVE Age | ||
Carlos Medeiros | GP Investments | 44 | |
Brackett Denniston | Cognizant Technology Solutions | 68 | |
Marcio Trigueiro | GP Investments | 42 | |
Thiago Rodrigues | GP Investments | 37 | |
Eduardo Alcalay | GP Investments | 46 | |
Carlos Silva | GP Investments | 44 | |
Alvaro Silva | GP Investments | 55 | |
Mara Sousa | GP Investments | N/A | |
Danilo Gamboa | GP Investments | 48 | |
Katie Royce | Cognizant Technology Solutions | N/A |
Management Performance
Return On Equity | 0.32 | |||
Return On Asset | 0.0955 |
Procter Gamble Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, CTO | ||
Matthew Janzaruk, VP Officer | ||
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures | ||
Kenneth Chenault, Independent Director | ||
Amy Chang, Independent Director | ||
Nelson Peltz, Director | ||
Martin Riant, Group President of Global Baby, Feminine and Family Care | ||
Hatsunori Kiriyama, President - Asia | ||
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations | ||
Francis Blake, Director | ||
Tarek Farahat, President - Latin America | ||
Mohamed Samir, President - India, Middle East and Africa | ||
Alexandra Keith, President - Global Hair Care and Beauty Sector | ||
Susan DesmondHellmann, Independent Director | ||
Valarie Sheppard, Principal Accounting Officer, Sr. VP, Comptroller and Treasurer | ||
Margaret Whitman, Independent Director | ||
Walter McNerney, Lead Independent Director | ||
Terry Lundgren, Independent Director | ||
Angela Braly, Independent Director | ||
Giovanni Ciserani, Group President of Global Fabric and Home Care | ||
James McNerney, Lead Independent Director | ||
Ernesto Zedillo, Independent Director | ||
Steven Bishop, Group President - Global Health Care | ||
Scott Cook, Independent Director | ||
Ernesto Leon, Independent Director | ||
Susan Whaley, Chief Sec | ||
Yannis Skoufalos, Global Product Supply Officer | ||
Linda ClementHolmes, CIO | ||
John Chevalier, Director - Investor Relations | ||
Juan Posada, President - Latin America Selling and Market Operations | ||
Fatima Francisco, Feminine Baby | ||
Alan Lafley, Chairman, CEO and President and Member of Proxy Committee | ||
Jeffrey Schomburger, Global Sales Officer | ||
Vittorio Cretella, Chief Officer | ||
Patricia Woertz, Independent Director | ||
Shailesh Jejurikar, Chief Officer | ||
Andre Schulten, Chief Officer | ||
Marc Pritchard, Global Brand Building Officer | ||
David Taylor, Group President - Global Health and Grooming | ||
Mark Biegger, Global Human Resources Officer | ||
Joseph Jimenez, Director | ||
Matthew Price, President - Greater China Selling and Market Operations | ||
Julio Nemeth, President - Global Business Services | ||
Deborah Majoras, Chief Legal Officer, Secretary | ||
Jon Moeller, CEO Pres | ||
Charles Pierce, Group President - Global Grooming | ||
Gary Coombe, President - Europe Selling and Market Operations | ||
Carolyn Tastad, Global Customer Business Development Officer | ||
Ken Patel, Chief Counsel |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.32 | |||
Return On Asset | 0.0955 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 2.06 T | |||
Shares Outstanding | 33.03 B | |||
Price To Earning | 102.83 X | |||
Price To Book | 8.36 X | |||
Price To Sales | 23.62 X | |||
Revenue | 80.19 B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in The Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade Procter Stock refer to our How to Trade Procter Stock guide.Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Procter Stock analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |